Press Releases July 21, 2026 08:00 AM

Arteris to Announce Financial Results for the Second Quarter 2026 on Thursday, August 6, 2026

Arteris Announces Q2 2026 Financial Results Release and Conference Call

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
AIP

Arteris, Inc., a semiconductor technology company focusing on AI-related innovations, will announce its second quarter 2026 financial results on August 6, 2026, followed by a management conference call. The company provides network-on-chip IP and SoC software solutions aimed at improving performance and engineering productivity in semiconductor design.

Arteris to Announce Financial Results for the Second Quarter 2026 on Thursday, August 6, 2026
AIP
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Arteris will release Q2 2026 financial results on August 6, 2026, after market close.
  • The company specializes in semiconductor IP and software that accelerate AI and SoC development.
  • A management conference call and webcast will discuss the results with investors and analysts.

CAMPBELL, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, today announced it will release its financial results for the second quarter ended June 30, 2026, after market close on Thursday, August 6, 2026.

Management will host a conference call on Thursday, August 6, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing:

United States/Canada Toll Free:         +1-800-717-1738
International Toll:                                 +1-646-307-1865

Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be available in the Investor Relations section of Arteris’ website at: https://ir.arteris.com/events-and-presentations.

A replay of the webcast will be available on the Events and Presentations page in the Investor Relations section of the company’s website approximately two hours after the conclusion of the call and remain available for approximately 30 calendar days.

About Arteris
Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation, and hardware security assurance. All are used by the world’s top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.

© 2004-2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.

Investor Contacts
Arteris Inc.
Nick Hawkins
Chief Financial Officer
[email protected]

Sapphire Investor Relations, LLC
Erica Mannion or Mike Funari
[email protected]
+1-617-542-6180


Risks

  • Financial performance for Q2 2026 is currently unknown, creating potential volatility post-announcement.
  • Market conditions and technological competition may impact Arteris's ability to maintain or grow its market position in semiconductor AI solutions.
  • Execution risks regarding the integration and adoption of their semiconductor IP and software products in a rapidly evolving AI sector.

More from Press Releases

Brookfield Infrastructure Announces Intention to Simplify Corporate Structure Jul 21, 2026 Brookfield Renewable Announces Intention to Simplify Corporate Structure Jul 21, 2026 TOP Financial Group Limited Announces Full Exercise of All Outstanding Warrants Following Cashless Exercise Jul 21, 2026 TLX591-Tx ProstACT SELECT Study Published in Cancers Journal Jul 21, 2026 Stride Announces Date for Fourth Quarter Fiscal Year 2026 Earnings Call Jul 21, 2026